Heyltex

Heyltex is a specialty pharmaceutical company based in Katy, Texas, serving as the exclusive U.S. subsidiary of the German firm Heyl Chemisch-pharmazeutische Fabrik. The company focuses on the distribution and marketing of critical antidotes and decorporation agents used in toxicology and emergency preparedness. Its flagship product, Radiogardase (Prussian blue), is FDA-approved for treating patients with known or suspected internal contamination with radioactive cesium or non-radioactive thallium. Heyltex plays a vital role in public health by providing essential medical countermeasures for radiological emergencies and heavy metal poisoning.